The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Buprenorphine Treatment Divide by Race/Ethnicity and Payment
Open accessAbstract
Buprenorphine Treatment Divide by Race/Ethnicity and PaymentOpioid mortality rates continue to increase throughout the United States 1 ; however, growth in buprenorphine hydrochloride treatment for opioid use disorder (OUD) might be limited to communities with higher income and low percentages of racial/ethnic minorities. 2 Buprenorphine, a partial opioid agonist, is 1 of 3 evidence-based medications for treating OUD and can legally be prescribed in office-based settings.To our knowledge, no national studies have examined the differences in the receipt of buprenorphine prescription by race/ethnicity and payment in office-based settings, in which most patients with buprenorphine prescription receive care. 3 In this article, we present changes in buprenorphine treatment at office-based visits in the United States since 2004 as well as the race/ethnicity and payment characteristics currently associated with its receipt.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trends in Black and White Opioid Mortality in the United States, 1979–2015
Alexander, M. J., Kiang, M. V., & Barbieri, M. (2018) · Epidemiology · doi:10.1097/ede.0000000000000858 · Cited by 205
Hansen, H., Siegel, C., Wanderling, J., & DiRocco, D. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.03.028 · Cited by 196
Medicaid benefits for addiction treatment expanded after implementation of the Affordable Care Act
Andrews, C. M., Grogan, C. M., Smith, B. T., Abraham, A. J., Pollack, H. A., Humphreys, K., Westlake, M. A., & Friedmann, P. D. (2018) · Health Affairs · doi:10.1377/hlthaff.2018.0272 · Cited by 54
Access to and Payment for Office-Based Buprenorphine Treatment in Ohio
Parran, T. V., Muller, J. Z., Chernyak, E., Adelman, C., Reyes, C. M. D., Rowland, D. Y., & Kolganov, M. (2017) · Substance Abuse Research and Treatment · doi:10.1177/1178221817699247 · Cited by 43
Buprenorphine Supply, Access, and Quality: Where We Have Come and the Path Forward
Breen, C. T., & Fiellin, D. A. (2018) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110518782934 · Cited by 9
Cited by
Stigma as a fundamental hindrance to the United States opioid overdose crisis response
Tsai, A. C., Kiang, M. V., Barnett, M. L., Beletsky, L., Keyes, K. M., McGinty, E. E., Smith, L. R., Strathdee, S. A., Wakeman, S. E., & Venkataramani, A. S. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002969 · Cited by 437
Kariisa, M., Davis, N. L., Kumar, S., Seth, P., Mattson, C. L., Chowdhury, F., & Jones, C. M. (2022) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7129e2 · Cited by 256
Metadata
- Authors
- Lagisetty, P. A., Ross, R., Bohnert, A., Clay, M., & Maust, D. T.
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2019-09-01
- Volume
- 76
- Issue
- 9
- Pages
- 979
- ISSN
- 2168-622X (ISSN-L)
- OpenAlex
- W2944661632
- Cited by
- 464
- References
- 5
- FWCI
- 47.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Buprenorphine Treatment Divide by Race/Ethnicity and Payment. https://app.cochat.ai/papers/10.1001/jamapsychiatry.2019.0876
- The paper
- Lagisetty, P. A., Ross, R., Bohnert, A., Clay, M., & Maust, D. T. (2019). Buprenorphine Treatment Divide by Race/Ethnicity and Payment. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2019.0876
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.